Portfolio company
Outpace
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotechnology company develops custom protein-based biological software to create smart cell therapies for patients with cancer and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Outpace Bio
This biotechnology company develops custom protein-designed cell therapies to treat solid tumours and autoimmune diseases for patients and pharmaceutical partners.
Modulari-T Biosciences
This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.
OverT
This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.
EpiBiologics
This company develops bispecific antibodies to degrade extracellular proteins for patients with cancer and autoimmune disorders.
InduPro
This biotechnology company develops proximity-based protein therapeutics for patients with cancer and autoimmune diseases.
Epana Bio
This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.
Arcellx
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
